{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:43:44Z","timestamp":1786718624052,"version":"build-2736575974"},"reference-count":106,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/aja.aja_6_18","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T07:15:47Z","timestamp":1518160547000},"page":"120","source":"Crossref","is-referenced-by-count":65,"title":["Randomized controlled trials \u2013 mechanistic studies of testosterone and the cardiovascular system"],"prefix":"10.4103","volume":"20","author":[{"given":"THugh","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DanielM","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.225173-1","first-page":"R47\u201371","volume-title":"Testosterone: a vascular hormone in health and disease","author":"Kelly","year":"2013","journal-title":"J Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-2","first-page":"909\u201315","volume-title":"Acute haemodynamic effects of testosterone in men with chronic heart failure","author":"Pugh","year":"2003","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1008-682X.225173-3","first-page":"1241\u20133","volume-title":"Effect of testosterone therapy on QT dispersion in men with heart failure","author":"Malkin","year":"2003","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/1008-682X.225173-4","first-page":"e415\u201321","volume-title":"Effects of testosterone on the Q-T interval in older men and older women with chronic heart failure","author":"Schwartz","year":"2011","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.225173-5","first-page":"819\u201334","volume-title":"Systematic literature review of the risk factors, comorbidities and consequences of hypogonadism in men","author":"Zarotsky","year":"2014","journal-title":"Andrology"},{"key":"key-10.4103\/1008-682X.225173-6","first-page":"76\u201383","volume-title":"The CAG repeat polymorphism within the androgen receptor gene and maleness","author":"Zitzmann","year":"2003","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.225173-7","first-page":"549\u201357","volume-title":"Testosterone propionate therapy in one hundred cases of angina pectoris","author":"Lesser","year":"1946","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.225173-8","first-page":"1217\u201322","volume-title":"Effect of testosterone cypionate on post exercise ST segment depression","author":"Jaffe","year":"1977","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1008-682X.225173-9","first-page":"415\u20138","volume-title":"Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients","author":"Wu","year":"1993","journal-title":"Chin Med J (Engl)"},{"key":"key-10.4103\/1008-682X.225173-10","first-page":"1906\u201311","volume-title":"Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study","author":"English","year":"2000","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.225173-11","first-page":"871\u20136","volume-title":"Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life","author":"Malkin","year":"2004","journal-title":"Heart"},{"key":"key-10.4103\/1008-682X.225173-12","first-page":"443\u20139","volume-title":"Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men","author":"Mathur","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-13","first-page":"50\u20135","volume-title":"Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease","author":"Cornoldi","year":"2010","journal-title":"Int J Cardiol"},{"key":"key-10.4103\/1008-682X.225173-14","first-page":"618\u201324","volume-title":"Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease","author":"Webb","year":"2008","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/1008-682X.225173-15","first-page":"437\u20139","volume-title":"Effect of acute testosterone on myocardial ischemia in men with coronary artery disease","author":"Webb","year":"1999","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/1008-682X.225173-16","first-page":"1666\u201370","volume-title":"Acute anti-ischemic effect of testosterone in men with coronary artery disease","author":"Rosano","year":"1999","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.225173-17","first-page":"249\u201356","volume-title":"Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease","author":"Thompson","year":"2002","journal-title":"Am Heart J"},{"key":"key-10.4103\/1008-682X.225173-18","first-page":"1690\u20136","volume-title":"Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease","author":"Webb","year":"1999","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.225173-19","first-page":"77\u201382","volume-title":"Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone","author":"English","year":"2000","journal-title":"Clin Sci"},{"key":"key-10.4103\/1008-682X.225173-20","first-page":"645\u201352","volume-title":"Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries","author":"English","year":"2001","journal-title":"Horm Metab Res"},{"key":"key-10.4103\/1008-682X.225173-21","first-page":"265\u201374","volume-title":"Effect of testosterone on ex vivo vascular reactivity in man","author":"Malkin","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"key-10.4103\/1008-682X.225173-22","first-page":"2675\u201380","volume-title":"Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone","author":"Hall","year":"2006","journal-title":"Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-23","first-page":"503\u20136","volume-title":"Testosterone is a potent inhibitor of L-type Ca2+ channels","author":"Scragg","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/1008-682X.225173-24","first-page":"733\u201344","volume-title":"The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?","author":"Jones","year":"2003","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/1008-682X.225173-25","first-page":"11\u20135","volume-title":"Molecular requirements for L-type Ca2+ channel blockade by testosterone","author":"Scragg","year":"2007","journal-title":"Cell Calcium"},{"key":"key-10.4103\/1008-682X.225173-26","first-page":"54\u201370","volume-title":"Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction","author":"Traish","year":"2007","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.225173-27","first-page":"105","volume-title":"Long-term survival of cancer patients compared to heart failure and stroke: a systematic review","author":"Askoxylakis","year":"2010","journal-title":"BMC Cancer"},{"key":"key-10.4103\/1008-682X.225173-28","first-page":"496\u2013501","volume-title":"Are the cardiac effects of anabolic steroid abuse in strength athletes reversible","author":"Urhausen","year":"2004","journal-title":"Heart"},{"key":"key-10.4103\/1008-682X.225173-29","first-page":"446\u20137","volume-title":"Testosterone treatment for men with chronic heart failure","author":"Pugh","year":"2004","journal-title":"Heart"},{"key":"key-10.4103\/1008-682X.225173-30","first-page":"57\u201364","volume-title":"Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial","author":"Malkin","year":"2006","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1008-682X.225173-31","first-page":"919\u201327","volume-title":"Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study","author":"Caminiti","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/1008-682X.225173-32","first-page":"392432","volume-title":"Beneficial effects of testosterone therapy on functional capacity, cardiovascular parameters, and quality of life in patients with congestive heart failure","author":"Mirdamadi","year":"2014","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/1008-682X.225173-33","first-page":"262\u20138","volume-title":"Testosterone and heart failure","author":"Malkin","year":"2010","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"key-10.4103\/1008-682X.225173-34","first-page":"138\u201342","volume-title":"Androgen deficiency in elderly men with systolic chronic heart failure","author":"Wang","year":"2010","journal-title":"J Geriatr Cardiol"},{"key":"key-10.4103\/1008-682X.225173-35","first-page":"442\u201350","volume-title":"Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure","author":"Jankowska","year":"2009","journal-title":"J Card Fail"},{"key":"key-10.4103\/1008-682X.225173-36","doi-asserted-by":"crossref","unstructured":"Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen and estrogen mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 1990; 294: 76\u201395.","DOI":"10.1002\/cne.902940107"},{"key":"key-10.4103\/1008-682X.225173-37","first-page":"2","volume-title":"Orchiectomy or androgen receptor blockade attenuates baroreflex-mediated bradycardia in conscious rats","author":"Ward","year":"2006","journal-title":"BMC Pharmacol"},{"key":"key-10.4103\/1008-682X.225173-38","first-page":"574\u20138","volume-title":"Heart failure: what causes the symptoms of heart failure?","author":"Coats","year":"2001","journal-title":"Heart"},{"key":"key-10.4103\/1008-682X.225173-39","first-page":"126\u201334","volume-title":"Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure","author":"Piepoli","year":"2006","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.225173-40","first-page":"940\u201352","volume-title":"Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training","author":"Piepoli","year":"1996","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.225173-41","first-page":"23\u20135","volume-title":"Inflammatory cytokines in heart failure: mediators and markers","author":"Gullestad","year":"2012","journal-title":"Cardiology"},{"key":"key-10.4103\/1008-682X.225173-42","first-page":"1368\u201375","volume-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","author":"Suskin","year":"2000","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1008-682X.225173-43","first-page":"19\u201324","volume-title":"Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition","author":"Doehner","year":"2010","journal-title":"Int J Cardiol"},{"key":"key-10.4103\/1008-682X.225173-44","first-page":"3313\u20138","volume-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men","author":"Malkin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.225173-45","first-page":"271\u201383","volume-title":"Physiologic testosterone therapy has no effect on serum levels of tumour necrosis factor-\u03b1 in men with chronic heart failure","author":"Pugh","year":"2005","journal-title":"Endocrine Res"},{"key":"key-10.4103\/1008-682X.225173-46","first-page":"479\u201393","volume-title":"Testosterone and insulin resistance in the metabolic syndrome and T2DM in men","author":"Rao","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-47","first-page":"44\u201350","volume-title":"The effect of testosterone on insulin sensitivity in men with heart failure","author":"Malkin","year":"2007","journal-title":"Eur J Heart Failure"},{"key":"key-10.4103\/1008-682X.225173-48","first-page":"278\u201384","volume-title":"Gender differences in autonomic modulation of ventricular repolarization in humans","author":"Nakagawa","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key-10.4103\/1008-682X.225173-49","first-page":"403\u201311","volume-title":"Sex-steroid hormones and the electrocardiographic QT-interval duration: findings from the third national health and nutrition examination survey and the multi-ethnic study of atherosclerosis","author":"Zhang","year":"2011","journal-title":"Am J Epidemiol"},{"key":"key-10.4103\/1008-682X.225173-50","first-page":"e132\u20138","volume-title":"Increased prevalence of prolonged QT duration in males with primary and secondary hypogonadism: a pilot study","author":"Pecori","year":"2010","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.225173-51","first-page":"2015\u20138","volume-title":"High prevalence of prolonged QT interval in obese hypogonadal males","author":"Pecori","year":"2011","journal-title":"Obesity"},{"key":"key-10.4103\/1008-682X.225173-52","first-page":"148\u201357","volume-title":"Sex and strain differences in adult mouse cardiac repolarization: importance of androgens","author":"Brouillette","year":"2005","journal-title":"Cardiovasc Res"},{"key":"key-10.4103\/1008-682X.225173-53","first-page":"740\u201351","volume-title":"Sex, hormones and repolarization","author":"Pham","year":"2002","journal-title":"Cardiovasc Res"},{"key":"key-10.4103\/1008-682X.225173-54","first-page":"2132\u20136","volume-title":"Testosterone diminishes the proarrhythmic effects of dofetilide in normal female rabbits","author":"Pham","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.225173-55","first-page":"161\u201373","volume-title":"Bio-available testosterone levels fall acutely following myocardial infarction in men: association with fibrinolytic factors","author":"Pugh","year":"2002","journal-title":"Endocr Res"},{"key":"key-10.4103\/1008-682X.225173-56","first-page":"937\u201352","volume-title":"Effect of potentially modifiable risk factors associated with myocardial function in 52 countries (the INTERHEART study): case-control study","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"key-10.4103\/1008-682X.225173-57","first-page":"146\u201356","volume-title":"Effects of testosterone on type 2 diabetes and components of the metabolic syndrome","author":"Jones","year":"2010","journal-title":"J Diabetes"},{"key":"key-10.4103\/1008-682X.225173-58","first-page":"528\u201340","volume-title":"Type 2 diabetes mellitus and testosterone: a meta-analysis study","author":"Corona","year":"2010","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.225173-59","first-page":"899\u2013906","volume-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes","author":"Kapoor","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-60","first-page":"602\u201312","volume-title":"Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study","author":"Kalinchenko","year":"2010","journal-title":"Clin Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-61","first-page":"3495\u2013503","volume-title":"Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24 month randomized, double-blind, placebo-controlled study","author":"Aversa","year":"2010","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.225173-62","first-page":"828\u201337","volume-title":"Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"key":"key-10.4103\/1008-682X.225173-63","first-page":"840\u201356","volume-title":"Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study","author":"Hackett","year":"2014","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.225173-64","first-page":"82\u201391","volume-title":"Insulin resistance and inflammation in hypogonadotrophic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes","author":"Dhindsa","year":"2016","journal-title":"Diabetes Care"},{"key":"key-10.4103\/1008-682X.225173-65","first-page":"2098\u2013107","volume-title":"Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial","author":"Gianatti","year":"2014","journal-title":"Diabetes Care"},{"key":"key-10.4103\/1008-682X.225173-66","first-page":"344\u201351","volume-title":"Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials","author":"Grossmann","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1008-682X.225173-67","first-page":"280\u201393","volume-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis","author":"Isidori","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1008-682X.225173-68","first-page":"e0162480","volume-title":"Treatment of men for 'low testosterone': a systematic review","author":"Huo","year":"2016","journal-title":"PloS One"},{"key":"key-10.4103\/1008-682X.225173-69","first-page":"318\u201327","volume-title":"The effect of testosterone on risk factors for, and the mediators of, the atherosclerotic process","author":"Jones","year":"2009","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1008-682X.225173-70","first-page":"581\u2013606","volume-title":"Testosterone and obesity","author":"Kelly","year":"2015","journal-title":"Obes Rev"},{"key":"key-10.4103\/1008-682X.225173-71","first-page":"414\u201333","volume-title":"Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups","author":"Traish","year":"2017","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"key-10.4103\/1008-682X.225173-72","first-page":"592\u2013602","volume-title":"The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes","author":"Kapoor","year":"2007","journal-title":"Eur J Endorcinol"},{"key":"key-10.4103\/1008-682X.225173-73","first-page":"285\u201391","volume-title":"Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina","author":"Smith","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-74","first-page":"287\u201393","volume-title":"NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages","author":"Bieghs","year":"2012","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1008-682X.225173-75","first-page":"531\u201341","volume-title":"Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial","author":"Hoyos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-76","first-page":"570\u201381","volume-title":"Effect of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels.a randomized clinical trial","author":"Basaria","year":"2015","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.225173-77","first-page":"708\u201316","volume-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.225173-78","first-page":"R25\u201345","volume-title":"Testosterone: a metabolic hormone in health and disease","author":"Kelly","year":"2013","journal-title":"J Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-79","unstructured":"Chen X, Li X, Huang HY, Li X, Lin JF. [Effects of testosterone on insulin receptor substrate-1 and glucose transporter 4 expression in cells sensitive to insulin]. Zhonghua Yi Xue Za Zhi 2006; 86: 1474\u201377. [Article in Chinese]."},{"key":"key-10.4103\/1008-682X.225173-80","first-page":"E961\u20138","volume-title":"Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle","author":"Sato","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.225173-81","first-page":"174\u201384","volume-title":"Testosterone stimulates glucose uptake and GLUT4 translocation through KKB\/AMPK signalling in 3T3-L1 adipocytes","author":"Mitsuhashi","year":"2016","journal-title":"Endocrine"},{"key":"key-10.4103\/1008-682X.225173-82","first-page":"504\u201315","volume-title":"Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse","author":"Kelly","year":"2016","journal-title":"Endocrine"},{"key":"key-10.4103\/1008-682X.225173-83","first-page":"2399\u2013407","volume-title":"Testosterone increases GLUT4-dependent glucose uptake in cardiomyocytes","author":"Wilson","year":"2013","journal-title":"J Cell Physiol"},{"key":"key-10.4103\/1008-682X.225173-84","first-page":"1133\u201343","volume-title":"Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells","author":"Antinozzi","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"key-10.4103\/1008-682X.225173-85","first-page":"1060\u20138","volume-title":"Lipoprotein lipase.A multifunctional enzyme relevant to common metabolic diseases","author":"Eckel","year":"1989","journal-title":"New Eng J Med"},{"key":"key-10.4103\/1008-682X.225173-86","first-page":"791\u20135","volume-title":"Effect of testosterone on abdominal adipose tissue in men","author":"Rebuffe-Scrive","year":"1991","journal-title":"Int J Obes"},{"key":"key-10.4103\/1008-682X.225173-87","first-page":"1018\u201322","volume-title":"Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone","author":"Marin","year":"1996","journal-title":"J Clin Endocrin Metab"},{"key":"key-10.4103\/1008-682X.225173-88","first-page":"45\u201353","volume-title":"Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men","author":"Volzke","year":"2010","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.225173-89","first-page":"95\u2013103","volume-title":"Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice","author":"Kelly","year":"2014","journal-title":"Life Sci"},{"key":"key-10.4103\/1008-682X.225173-90","first-page":"1042\u201352","volume-title":"Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue","author":"Yu","year":"2005","journal-title":"Circ Res"},{"key":"key-10.4103\/1008-682X.225173-91","first-page":"1072\u201381","volume-title":"Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis","author":"McInnes","year":"2012","journal-title":"Diabetes"},{"key":"key-10.4103\/1008-682X.225173-92","first-page":"P173","volume-title":"Testosterone stimulates cholesterol metabolism and efflux from human macrophages via liver X receptor","author":"Kilby","year":"2013","journal-title":"Endocrine"},{"key":"key-10.4103\/1008-682X.225173-93","first-page":"95\u2013102","volume-title":"Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men","author":"Van","year":"2003","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1008-682X.225173-94","first-page":"624\u201330","volume-title":"Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes","author":"Stanworth","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1008-682X.225173-95","first-page":"183\u2013217","volume-title":"Androgens and coronary artery disease","author":"Wu","year":"2003","journal-title":"Endocrine Rev"},{"key":"key-10.4103\/1008-682X.225173-96","first-page":"2192\u20139","volume-title":"Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits","author":"Bruck","year":"1997","journal-title":"Arterio Thromb Vasc Biol"},{"key":"key-10.4103\/1008-682X.225173-97","first-page":"813\u20139","volume-title":"Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits","author":"Alexandersen","year":"1999","journal-title":"Circ Res"},{"key":"key-10.4103\/1008-682X.225173-98","first-page":"2427\u201334","volume-title":"Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor","author":"Nettleship","year":"2007","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.225173-99","doi-asserted-by":"crossref","unstructured":"Kelly DM, Sellers DJ, Woodroofe MN, Jones TH, Channer KS. Effect of testosterone on inflammatory markers in the development of early atherogenesis in the testicular-feminized mouse model. Endocrine Res 2013; 38; 125\u201338.","DOI":"10.3109\/07435800.2012.735307"},{"key":"key-10.4103\/1008-682X.225173-100","first-page":"5428\u201337","volume-title":"Androgen receptor-dependent and independent atheroprotection by testosterone in male mice","author":"Bourghardt","year":"2010","journal-title":"Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-101","first-page":"595\u2013604","volume-title":"Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency","author":"Corrales","year":"2006","journal-title":"J Endocrinol"},{"key":"key-10.4103\/1008-682X.225173-102","first-page":"293\u2013305","volume-title":"Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis","author":"Alexander","year":"2017","journal-title":"Am J Med"},{"key":"key-10.4103\/1008-682X.225173-103","first-page":"109\u201322","volume-title":"Adverse effects associated with testosterone administration","author":"Basaria","year":"2010","journal-title":"New Engl J Med"},{"key":"key-10.4103\/1008-682X.225173-104","first-page":"639\u201350","volume-title":"Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study","author":"Srinvas-Shankar","year":"2010","journal-title":"L Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.225173-105","first-page":"179\u201389","volume-title":"Low free testosterone predicts mortality from cardiovascular disease but not other causes: the health in men study","author":"Hyde","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.225173-106","first-page":"2706\u201315","volume-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","author":"Sharma","year":"2015","journal-title":"Eur Heart J"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:37:35Z","timestamp":1786714655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aja.aja_6_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"alternative-id":["225173"],"URL":"https:\/\/doi.org\/10.4103\/aja.aja_6_18","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}